Russell Investments Group Ltd. increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 18.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 249,666 shares of the semiconductor company’s stock after acquiring an additional 39,209 shares during the period. Russell Investments Group Ltd.’s holdings in Synopsys were worth $108,172,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of SNPS. BlackRock Inc. bought a new stake in shares of Synopsys during the second quarter worth $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Synopsys in the second quarter valued at about $747,400,000. Bank of New York Mellon Corp acquired a new position in Synopsys during the 2nd quarter worth about $692,074,000. Bank of America Corp DE acquired a new position in Synopsys during the 2nd quarter worth about $539,986,000. Finally, Legal & General Group Plc bought a new stake in Synopsys during the 2nd quarter worth about $491,923,000. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Stock Performance
Synopsys stock opened at $455.20 on Monday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48. The company has a market cap of $87.23 billion, a PE ratio of 80.42, a PEG ratio of 1.44 and a beta of 1.18. The company’s 50-day moving average is $445.16 and its two-hundred day moving average is $441.11.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same quarter last year, the firm earned $3.39 EPS. The company’s revenue for the quarter was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts anticipate that Synopsys, Inc. will post 11.01 earnings per share for the current year.
Synopsys announced that its Board of Directors has initiated a stock repurchase plan on Monday, October 5th that allows the company to buy back $1 billion in shares. This repurchase authorization allows the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its stock is undervalued.
Insider Transactions at Synopsys
In other news, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the sale, the chief executive officer directly owned 76,865 shares in the company, valued at $35,576,196.60. This trade represents a 15.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares in the company, valued at $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 117,163 shares of company stock worth $51,366,457 in the last 90 days. 0.56% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on the stock. KeyCorp raised their price objective on shares of Synopsys from $600.00 to $605.00 and gave the company an “overweight” rating in a research report on Thursday, October 1st. BNP Paribas Exane upped their target price on shares of Synopsys from $420.00 to $475.00 and gave the stock a “neutral” rating in a research report on Thursday, October 1st. UBS Group set a $570.00 price target on shares of Synopsys in a research note on Thursday, August 27th. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. Finally, Rosenblatt Securities boosted their price objective on shares of Synopsys from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $575.00.
Get Our Latest Analysis on Synopsys
Synopsys Company Profile
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Further Reading
- Five stocks we like better than Synopsys
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
